AbbVie Forecasts 2022 Adjusted Earnings Ahead of Analyst Expectations
February 02 2022 - 8:36AM
Dow Jones News
By Matt Grossman
AbbVie Inc.'s adjusted-earnings guidance for 2022 exceeds the
level that Wall Street analysts have forecast.
The North Chicago, Ill.-based pharmaceutical company said it
expects 2022 adjusted earnings of $14 to $14.20 a share. Analysts
polled by FactSet had been projecting adjusted earnings of $13.99 a
share.
AbbVie said its adjusted earnings guidance excludes $4.74 a
share of amortization expenses on intangible assets, non-cash
charges for contingent consideration adjustments and other
items.
The guidance, part of AbbVie's release of fourth-quarter
earnings results on Wednesday, helped send shares 1.1% higher in
premarket trading.
Write to Matt Grossman at matt.grossman@wsj.com
(END) Dow Jones Newswires
February 02, 2022 08:21 ET (13:21 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Jun 2024 to Jul 2024
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Jul 2023 to Jul 2024
